LIPO
Lipella Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.00
+0.00%Margins
Gross margin
-1954.7%
EBITDA margin
-3067.3%
EBIT margin
-3115.2%
Net margin
-3069.0%
FCF margin
—
-358.3%
Return on equity
-226.8%
Return on assets
-308.8%
Return on invested capital
0.06x
Asset turnover
-$2.4B
Cash from operations
$0.41
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2025